FMI Good Growth Opportunities in Cloud-Based Drug Disc | Page 5

Cloud-Based Drug Discovery Platform Market
Currently, cloud-based drug discovery platform is witnessing a period of technological advancement, as
innovative features, such as publishing and sharing services are being offered to users. Cloud-based drug
discovery platform is accessible through computers, notebook, and mobiles, and it is secure and can be
maintained by a third party as well. Owing to all these factors, the cloud-based drug discovery platform
market is anticipated to grow at a significant rate in terms of value.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1591
Cloud-Based Drug Discovery Platform Market Segmentation
On the basis of types of services, the cloud-based drug discovery platform market is segmented into
infrastructure as a Service (IaaS), Platform as a Service (PaaS) and Software as a Service (SaaS). IaaS offers
data-center space, and servers, network equipment such as software for businesses and
routers/switches. PaaS offers full hardware architecture and software framework. In SaaS process
providers allow access to software through online medium only.
Geographically, global cloud-based drug discovery market is segmented into North America, Latin
America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.
North America and Western Europe are the leading players in the cloud-based drug discovery platform
market. The growth of the market in Asia Pacific is anticipated to witness steady growth over the forecast
period.
©2015 Future Market Insights, All Rights Reserved

5